echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Nature's heavyweight: Overcoming the problem of bacterial resistance, a new type of synthetic antibiotic may become the "nemesis" of resistant bacteria!

    Nature's heavyweight: Overcoming the problem of bacterial resistance, a new type of synthetic antibiotic may become the "nemesis" of resistant bacteria!

    • Last Update: 2021-11-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Nowadays, the problem of bacterial resistance caused by the abuse of antibiotics is becoming a public health issue of increasing concern around the world.
    In addition to calling on all sectors of society to use antibiotics rationally, the development of new antibiotics to overcome bacterial resistance has also become a problem that scientists need to overcome
    .


     

    Nowadays, the problem of bacterial resistance caused by the abuse of antibiotics is becoming a public health issue of increasing concern around the world.


    For 50 years, the search and development of antibiotics has always relied on the semi-synthetic chemical modification of natural products.
    However, this method is no longer able to cope with the rapidly evolving bacterial resistance threat, and the fully synthetic chemical modification will be able to easily be designed with reasonable design.


    DOI : https://doi.


    org/10.


    DOI : https://doi.


    In this study, the researchers used the lincosamide antibiotic clindamycin as the research object to synthesize a new antibiotic


    The researchers first generated 500 antibiotic drug candidates based on the combination of no chemical bonds .
    After a series of tests, they selected one of the more active antibiotics and named it iboxamycin ( IBX )


    Subsequently, the researchers used standard strains of Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus to study the activity of IBX in mice.
    The results showed that IBX achieved a statistically significant reduction in bacterial load 12 hours after treatment of mice.
    .
    In the systemic infection model, IBX is well tolerated and safe at all dose levels .
    At the same time, X -ray imaging results show that iboxamycin can shift methylated ribosomal nucleotides, exposing the drug binding site, so that the drug can still bind to and overcome the ribosome when the ribosome has been methylated.


    Figure: Antibacterial activity of broad-spectrum antibiotic IBX in vitro and in vivo in mice

    Figure: Antibacterial activity of broad-spectrum antibiotic IBX in vitro and in vivo in mice

    The researchers said that this discovery proves the importance of synthetic chemistry and is more helpful in the development of synthetic antibiotics against drug-resistant bacteria
    .

    The researchers said that this discovery proves the importance of synthetic chemistry and is more helpful in the development of synthetic antibiotics against drug-resistant bacteria
    .


    Reference materials:

    [1]https://#citeas

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.